Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2024-07-18 Annual Report
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Annual Report Classification · 95% confidence The document is dated July 18, 2024, and is addressed to stock exchanges and shareholders. It announces the Annual Report for the financial year 2023-24 and the Notice of the 33rd Annual General Meeting (AGM) of Mankind Pharma Limited. The text includes detailed information about the AGM date, e-voting procedures, agenda items including adoption of standalone and consolidated audited financial statements for the year ended March 31, 2024, appointment and re-appointment of auditors, and other AGM-related formalities. It also references compliance with SEBI and MCA regulations regarding AGM through video conferencing. The document contains the full Notice of the AGM with ordinary and special business resolutions, director re-appointment details, and procedural notes. The length is substantial (15,000 characters), and the content is the actual Notice and Annual Report for the fiscal year 2023-24, not merely an announcement or a link to the report. Therefore, this document is the Annual Report itself combined with the AGM Notice, which is typical in Indian filings. Given the primary focus on the Annual Report and financial statements for the fiscal year 2023-24, the appropriate classification is Annual Report (10-K). FY 2024
2024-07-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming no requests for dematerialization/rematerialization of shares for the quarter ended June 30, 2024. It is a compliance certificate from the Registrar and Share Transfer Agent addressed to the stock exchanges and the company secretary. The document is short (2004 characters) and primarily serves as a regulatory compliance filing rather than a financial report or announcement of a report. It does not contain financial data, management discussion, or shareholder voting results. It is an officer certification type document related to regulatory compliance. According to the rules, such certifications should be classified as Regulatory Filings (RNS).
2024-07-11 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of a newspaper advertisement about the upcoming Annual General Meeting (AGM) of the company Mankind Pharma Limited. It references compliance with SEBI regulations and mentions the AGM date and e-voting information. The content is about informing the exchanges and public about the AGM notice publication, not the AGM materials themselves or the AGM meeting minutes. The document is relatively short and serves as an announcement of the advertisement publication rather than the AGM report or presentation. Therefore, it fits best under the category of AGM Information (AGM-R) as it relates to AGM-related communication, specifically the advertisement notice for the AGM.
2024-07-10 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a short notice dated July 9, 2024, addressed to stock exchanges, informing about the assignment of credit ratings by credit rating agencies ICRA Limited and CRISIL Ratings Limited for a non-convertible debenture instrument. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an update on credit rating assigned, which is a financing-related update but not a full financial report or earnings release. The document length is only 1529 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits best under Capital/Financing Update (CAP).
2024-07-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice from Mankind Pharma Limited addressed to stock exchanges regarding the closure of the trading window under SEBI regulations due to the upcoming declaration of unaudited quarterly financial results for the quarter ending June 30, 2024. It mentions the trading window closure period and that the date of the board meeting for declaring results will be intimated later. The document does not contain any financial data or results itself, nor does it include a report or detailed financial analysis. It is an announcement related to compliance and insider trading restrictions ahead of an interim financial report. The document length is short (1669 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance notices that do not fit other specific categories.
2024-06-26 English
Shareholders meeting
Regulatory Filings
2024-06-18 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.